`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`AYLA PHARMA LLC
`Petitioner.
`
`V.
`
`ALCON RESEARCH, LTD.,
`Patent Owner.
`
`U.S. Patent No. 9,533,053 to Gamache et al.
`Issue Date: January 3,2017
`Title: High Concentration Olopatadine Ophthalmic Composition
`
`Inter Partes Review No.: IPM020-00295
`
`PETITIONER'S POWER OF ATTORNEY
`
`Msil Stop "PATENT BOARD"
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria. VA 223 13-1450
`
`US 142619490v1 393607-00001
`
`
`
`PETTTIONER'S POWER OF ATTORNEY
`Pursuant to 37 C.F.R. 5 42.10(b), Petitioner Ayla Pharma LLC having a
`principal place of business at 23 Corporate P\aza, Suite 150, Newport Beach, CA'
`
`92660,hereby appoints the following practitioners as its attorneys to transact all
`
`business in the United States Patent & Trademark Office Association with any
`
`inter partes review of U.S. Patent No 9,533,053:
`
`Lead Counsel
`Jitendra Malik, Ph.D.
`Reg. No. 55,823
`Katten Muchin Rosenman LLP
`550 S. Tryon Street, Suite 2900
`Charlotte, NC 28202-4213
`j itty. mal ik@katten com
`
`Back-up Counsel
`Alissa M. Pacchioli
`Reg. No. 74,252
`Katten Muchin Rosenman LLP
`550 S. Tryon Street, Suite 2900
`Charlotte, NC 28202-4213
`al i s s a. p ac chio I i @katten. c om
`
`Guylaine Hach6, Ph.D.
`Reg. No. 76,083
`Katten Muchin Rosenman LLP
`525 W. Monroe Street
`Chicago, IL 60661-3693
`guyl aine. hache @katten. c om
`
`and all practitioners associated with Customer Number 27160.
`
`US 142619490v1 393607-0000 I
`
`
`
`I have the authority to execute this document on behalf of Ayla
`
`Pharma LLC.
`
`%Le- /</rtq@
`
`Title: President
`Date: December 23 ,2019
`
`US 142619490v1 393607-00001
`
`